Sponsor:
Collagen Matrix
Code:
NCT04775537
Conditions
Spinal Disease
Degenerative Disc Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OssiMend™ Bioactive Moldable
Brief summary:
Conditions
Spinal Disease
Degenerative Disc Disease
Study ID
NCT04775537
Start date
Jan 21, 2021
Status verified date
Jan, 2025
Completion date
Jan 30, 2027
Anticipated
Primary completion date
Dec 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Arms
OssiMend™ Bioactive Moldable
Interventions
OssiMend™ Bioactive Moldable
Primary outcome measure
Central contacts
Locations
Hartford Hospital
Recruiting
Hartford, Connecticut, United States, 06102
Contacts
Principal Investigator:
Pedro Coutinho, MD
Sponsor
Collagen Matrix
Last update posted
Oct 16, 2025
Last verified
Jan, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Collagen Matrix on 2025-10-16.